Preparedness today, safer tomorrow
Emergent BioSolutions (emergentbiosolutions.com) scores 80 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Government brands, Manufacturing brands, in the 70th percentile of 6207 Healthcare brands.
Emergent BioSolutions is a multinational biopharmaceutical company headquartered in Gaithersburg, Maryland, founded in 1998. It develops and manufactures specialty products designed to protect civilian and military populations from intentional and naturally emerging public health threats, including biological and chemical agents, as well as endemic issues such as the opioid epidemic. The company serves government agencies, military organizations, and healthcare systems by combining life sciences expertise with large-scale manufacturing capabilities to deliver protective and life-saving countermeasures.
| Brand Name | Emergent BioSolutions |
|---|---|
| Domain | emergentbiosolutions.com |
| Industry | Healthcare, Government |
| Founded | 1998 |
| Headquarters | Gaithersburg |
| Main Competitors | Bavarian Nordic, SIGA Technologies, PharmAthene, Dynavax Technologies, Amphastar Pharmaceuticals (66/100), Hikma Pharmaceuticals (87/100) |
Moz Domain Authority 57/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #320,882 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Emergent BioSolutions has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Emergent BioSolutions provides specialty products for civilian and military populations that address intentional and naturally emerging public health threats." (Meta description: 19 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, Instagram, X (Twitter), YouTube, GitHub; no detected presence on Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Emergent BioSolutions?", Claude could identify the brand as of September 2026. Emergent BioSolutions is a biopharmaceutical company focused on public health preparedness, best known for manufacturing vaccines and treatments for biological and chemical threats, including anthrax vaccines and the opioid overdose reversal nasal spray Narcan. Best known for Being a major manufacturer of Narcan (naloxone nasal spray) and anthrax vaccines for the U.S. government's biodefense stockpile.
When asked "Best brands similar to Emergent BioSolutions?", Claude would recommend Emergent BioSolutions as of September 2026. It's a notable name in biodefense and public health preparedness, especially relevant if discussing companies involved in government stockpiling programs or naloxone products.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Emergent BioSolutions's main competitors in Healthcare: Amphastar Pharmaceuticals (66/100), Hikma Pharmaceuticals (87/100).
Sources: Brand Analyzer scan
Emergent BioSolutions is a multinational biopharmaceutical company headquartered in Gaithersburg, Maryland, USA, founded in 1998. It specializes in developing specialty products that protect civilian and military populations from intentional and naturally emerging public health threats.
Sources: Emergent BioSolutions official site
Emergent BioSolutions has moderate AI-search visibility, scoring 57/100 on Brand Analyzer's AI visibility composite (visibility 70, trust 33, recommendation 62). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Emergent BioSolutions official site
Emergent BioSolutions was founded in 1998. Emergent BioSolutions operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Emergent BioSolutions is headquartered in Gaithersburg. Emergent BioSolutions operates in the Healthcare category.
Sources: Wikidata
Emergent BioSolutions develops, manufactures, and supplies specialty medical products designed to counter biological, chemical, and other public health threats. Its work includes countermeasures for bioterrorism, public health emergencies, and endemic issues such as the opioid epidemic, serving both civilian and military populations.
Sources: Emergent BioSolutions official site
Emergent BioSolutions scores 62/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Emergent BioSolutions official site
Emergent BioSolutions can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Emergent BioSolutions official site
Emergent BioSolutions offers specialty products addressing public health threats, including countermeasures for biological and chemical agents, and products aimed at combating the opioid epidemic. These are designed for use by government agencies, military organizations, and civilian health systems.
Sources: Emergent BioSolutions official site
Emergent BioSolutions' products are used by government agencies, military organizations, healthcare systems, and civilian populations seeking protection against public health emergencies and biothreats.
Sources: Emergent BioSolutions official site
Emergent BioSolutions is known for developing biodefense countermeasures and specialty pharmaceutical products aimed at protecting populations from bioterrorism, chemical threats, and public health emergencies, as well as products addressing the opioid epidemic.
Sources: Emergent BioSolutions official site
Emergent BioSolutions scores 57/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Emergent BioSolutions has a limited AI-visibility profile at 57/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (70/100) and its weakest is trust (33/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #320,882 (Tranco). The main gaps holding it back: thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Emergent BioSolutions from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Emergent BioSolutions: Emergency Reporting (80/100), Elior Group (80/100), Enrollware (80/100), Epic (80/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), ZOLL Data Systems (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.